CODEai

The CODEai state-of-the-art informatics system and big data architecture provides an unmatched resource for developing a better understanding of the molecular mechanisms of cancer and helps researchers and biopharmaceutical companies derive unique insights to support commercial and product development objectives, clinical trial services, target identification and research initiatives.

CODEai 4.0

Dear CODEai users,

We are pleased to announce that CODEai 4.0 officially launched on October 21st, 2026, available at https://codeai.caris.ai. CODEai 4.0 now features an expanded database of 778K records, while continuing to provide access to the previous 484K-record dataset.

The current application will retire on November 4th, 2026.

All of your user data including saved cohorts created before October 21st have been migrated to CODEai 4.0. Any customized data created after October 21st in the current application will need to be recreated in the new system. We encourage all users to transition to the new application as soon as possible. For a quick introduction to the new application, please visit the Resources page in CODEai 4.0 to access tutorial videos.

Thank you!

Open CODEai 4.0

Caris CODEai™ is the most comprehensive, real-world data platform integrating Caris’ extensive catalog of molecular data.